Mark Winstanley

Ewing Sarcoma with Novel Translocation t(2;16) Producing an In-Frame Fusion of FUS and FEV

Tony Ng, Maureen J. O’Sullivan, Catherine J. Pallen et al. · Journal of Molecular Diagnostics · 2007 · 156 citations · Full text

Medicine, Oncology, Pathology +12

Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster AML-study group

Eva A. Coenen, C. Michel Zwaan, Dirk Reinhardt et al. · Blood · 2013 · 108 citations · Full text

Medicine, Hematology, Pediatrics +14

Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care

Pallav L. Shah, Christopher M. Orton, Beatriz Grinsztejn et al. · The Lancet Respiratory Medicine · 2022 · 57 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Results of the second interim assessment of rEECur, an international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES).

Martin G. McCabe, Laura Kirton, Maria Khan et al. · Journal of Clinical Oncology · 2020 · 45 citations · Full text

Medicine, Oncology, Cancer Drug Toxicity Management +14

Results of the first interim assessment of rEECur, an international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma.

Martin G. McCabe, V. V. Moroz, Maria Khan et al. · Journal of Clinical Oncology · 2019 · 42 citations · Full text

Medicine, Oncology, Cancer Drug Toxicity Management +14